19
Participants
Start Date
January 31, 2009
Primary Completion Date
June 30, 2011
Study Completion Date
December 31, 2011
placebo
A total of 2 cc sterile normal saline: will be injected in 0.5 cc aliquots into 4 different injectate sites within the rectus femoris (with EMG guidance) of the involved limb.
botulinum toxin A (BTX-A)
200 Units BTX-A reconstituted with 2 cc sterile normal saline in 100:1 ratio. Teflon-coated EMG guidance for confirmation of injection into the Rectus femoris muscle in addition to utilizing standardized injection landmarks, the solution will be injected in 0.5 cc aliquots into 4 different injectate sites within the muscle.
Mary Free Bed Rehabilitation Hospital, Grand Rapids
Collaborators (1)
Allergan
INDUSTRY
Mary Free Bed Rehabilitation Hospital
OTHER